URGN - UroGen Pharma Ltd. Ordinary Shares -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
UroGen Pharma Ltd. Ordinary Shares
UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.
IPO Date: May 4, 2017
Sector: Healthcare
Industry: Biotech
Related Tickers:
AMGN GILD VRTX REGN MRNA ARGX IQV RVMD ONC BIIB
Market Cap: $1.68B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.66 | 3.17%
Avg Daily Range (30 D): $0.93 | 2.44%
Avg Daily Range (90 D): $1.06 | 2.58%
Institutional Daily Volume
Avg Daily Volume: .34M
Avg Daily Volume (30 D): .78M
Avg Daily Volume (90 D): .72M
Trade Size
Avg Trade Size (Sh.): 84
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 64
Institutional Trades
Total Institutional Trades: 1,142
Avg Institutional Trade: $2.16M
Avg Institutional Trade (30 D): $5.51M
Avg Institutional Trade (90 D): $3.7M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.39M
Avg Closing Trade (30 D): $6.88M
Avg Closing Trade (90 D): $5.29M
Avg Closing Volume: 108.23K
 
News
Nov 4, 2026 @ 2:05 PM
Urogen Pharma (URGN) Reports Q3 Loss, Beats Revenu...
Source: Na
Nov 2, 2026 @ 1:00 PM
UroGen Announces First Patient Dosed in Phase 1 Tr...
Source: Na
Oct 27, 2026 @ 10:00 PM
UroGen Pharma to Report Third Quarter 2026 Financi...
Source: Na
Sep 30, 2026 @ 1:11 PM
Here's Why You Should Add URGN Stock to Your Portf...
Source: Na
Sep 8, 2026 @ 12:33 PM
Take the Zacks Approach to Beat the Markets: Oport...
Source: Zacks.Com